Cabot Corporation

NYSE:CBT

Chemicals - Specialty

Basic Materials
$74.03 +1.09%

+$0.96 today

Market cap
$3.80B
Beta
0.83
P/E (TTM)
16.3
EPS (TTM)
$5.48
Dividend yield
2.04%
52W Low $58.33High $90.08

Volume 0.53M

Average 0.43M

CBT Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Cabot CorporationNYSE: CBT

Net Income · Q3 FY2026 · quarter ended Jun 2026

Net income declines year over year

Q3 FY2026 net income of $35M fell 65.3% year over year, behind the -51.5% change in trailing-twelve-month net income. Sequentially, it fell 47.8% from the prior quarter. Over 3 fiscal years it compounded at +15.7% a year.

Context

  • Net income amounted to 10.1% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 4 analysts of $333.66M (-11.3%) for the fiscal year ending Sep 2026, a pace similar to FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$35M-47.8% QoQ
Last fiscal yearSep 2025
$376M-11.3% YoY
LTMJun 2026
$217M-51.5% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-65.3%+86.6%+151.9 pp
1 year-11.3%-11.3%+0.1 pp
3-year CAGR+15.7%+0.9%-14.7 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
376M USD
Year-over-year change
-11.3%
4-year CAGR
+7.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How CBT compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -51.5% is the 10th highest of 11, against a peer median of -8.5%.
  • Net income amounts to 6.0% of revenue for CBT, versus a peer median of 6.5%.
CBT Competitors
Net Income for CBT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SSLSasol LimitedFY2026ZAR 11.9B ZAR-36.8%+10.6%4.5%
CECelanese CorporationLTM Jun 2026$1.16B USD-28.0%—11.9%
CBTCabot CorporationLTM Jun 2026$217M USD-51.5%+15.7%6.0%
FULH.B. Fuller CompanyLTM Aug 2026$197.76M USD+71.8%-5.6%5.6%
AVNTAvient CorporationLTM Sep 2026$181.9M USD+58.3%-50.8%5.3%
SXTSensient Technologies CorporationLTM Jun 2026$157.97M USD+17.2%-1.5%9.3%
KNFKnife River CorporationLTM Jun 2026$139.89M USD-8.7%+10.6%4.2%
MEOHMethanex CorporationLTM Jun 2026$98.89M USD-67.7%-44.0%2.3%
HWKNHawkins, Inc.LTM Sep 2026$85.81M USD+3.2%+10.7%7.5%
WDFCWD-40 CompanyLTM Aug 2026$82.35M USD-9.4%+7.7%12.0%
PRMPerimeter Solutions, Inc.LTM Jun 2026$72.94M USD-8.3%—9.6%
Peer median (excluding CBT) —-8.5%+3.1%6.5%

Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income286M243M484M424M376M
Depreciation & Amortization160M146M144M151M154M
Deferred Income Tax9M(40M)(156M)(37M)32M
Stock-Based Compensation21M23M20M25M24M
Change in Working Capital(244M)(448M)100M70M49M
Accounts Receivables7M(287M)153M(26M)76M
Inventory(174M)(259M)96M41M47M
Accounts Payables167M115M(152M)42M(67M)
Other Working Capital(244M)(17M)3M13M(7M)
Other Non-Cash Items25M176M3M59M30M
Operating Cash Flow257M100M595M692M665M
Capital Expenditures(195M)(211M)(244M)(241M)(274M)
Acquisitions (Net)(92M)70M6M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities101M23M24M6M(24M)
Investing Cash Flow(186M)(118M)(214M)(235M)(298M)
Debt Repayment36M298M(179M)(143M)(23M)
Common Stock Issued6M6M4M20M8M
Common Stock Repurchased(3M)(53M)(98M)(172M)(168M)
Dividends Paid(80M)(84M)(88M)(93M)(96M)
Other Financing Activities(19M)(22M)(42M)(27M)(57M)
Financing Cash Flow(60M)145M(403M)(415M)(336M)
Effect of Forex Changes8M(91M)54M(57M)4M
Net Change in Cash19M36M32M(15M)35M
Free Cash Flow62M(111M)351M451M391M

Cabot Corporation

NYSE:CBT

Intrinsic Alpha fair value

Locked

Current Price

$74.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.